A mixed methods feasibility study of nicotine-assisted smoking reduction programmes delivered by community pharmacists – The RedPharm study
Abstract Background Pivotal trials have established that, among people who have no immediate intention to quit smoking, nicotine replacement therapy (NRT) helps people reduce and eventually stop smoking. The prime aim of this trial was to investigate the feasibility of implementing such a programme...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-02-01
|
Series: | BMC Public Health |
Online Access: | http://link.springer.com/article/10.1186/s12889-017-4116-z |
_version_ | 1811283227075149824 |
---|---|
author | Amanda Farley Sarah Tearne Taina Taskila Rachel H. Williams Susan MacAskill Jean-Francois Etter Paul Aveyard |
author_facet | Amanda Farley Sarah Tearne Taina Taskila Rachel H. Williams Susan MacAskill Jean-Francois Etter Paul Aveyard |
author_sort | Amanda Farley |
collection | DOAJ |
description | Abstract Background Pivotal trials have established that, among people who have no immediate intention to quit smoking, nicotine replacement therapy (NRT) helps people reduce and eventually stop smoking. The prime aim of this trial was to investigate the feasibility of implementing such a programme in community pharmacies. In addition, we investigated the effectiveness of providing behavioural support compared with self-help methods and of shorter compared with standard length reduction programmes. Methods Pharmacists were trained to deliver a smoking reduction programme and opportunistically invite people to participate in the programme. In a 2 × 2 factorial design, eligible volunteers were randomised to either receive in-person behavioural support or a self-help booklet. In both cases, participants were supported to set targets to reduce their smoking and use behavioural techniques to assist reduction. In addition, participants were randomised to cut down and stop over 4 weeks or over 16 weeks, but in either case continue NRT for up to nine months. We assessed uptake and adherence to the programme and smoking cessation four weeks and six months after a quit day and reduction in the three months following programme end and incorporated a qualitative processes assessment. Results Only 68 of the planned 160 smokers could be recruited. Pharmacists were deterred by the bureaucracy of trial enrolment and that many smokers did not return for further support. Pharmacists sometimes subverted the randomisation or provided support to participants in the self-help arm. Smokers stayed in the programme for an average of 6 weeks rather than the 9 months envisaged. Rates of follow-up declined to around 20% of participants by 12 months. There was insufficient evidence to assess whether support or speed of reduction enhanced cessation or reduction but cessation and reduction were less common overall than in the pivotal trials for licensing NRT for this indication. Conclusions This programme of smoking reduction and the trial design to assess its effectiveness proved unpopular to potential participants and pharmacists. As a result, the trial produced no evidence on the effectiveness of behavioural support or speed or smoking reduction. A trial of this programme in this context is unfeasible. Trial registration ISRCTN 54805841 . Registered 18 March 2010. |
first_indexed | 2024-04-13T02:07:37Z |
format | Article |
id | doaj.art-cde8bf2fd6f246afba2013f7349780fc |
institution | Directory Open Access Journal |
issn | 1471-2458 |
language | English |
last_indexed | 2024-04-13T02:07:37Z |
publishDate | 2017-02-01 |
publisher | BMC |
record_format | Article |
series | BMC Public Health |
spelling | doaj.art-cde8bf2fd6f246afba2013f7349780fc2022-12-22T03:07:26ZengBMCBMC Public Health1471-24582017-02-0117111510.1186/s12889-017-4116-zA mixed methods feasibility study of nicotine-assisted smoking reduction programmes delivered by community pharmacists – The RedPharm studyAmanda Farley0Sarah Tearne1Taina Taskila2Rachel H. Williams3Susan MacAskill4Jean-Francois Etter5Paul Aveyard6Institute of Applied Health Sciences, University of BirminghamNuffield Department of Primary Care Health Sciences, University of OxfordDepartment of Family Care & Mental Health, Faculty of Education & Health, University of GreenwichNuffield Department of Primary Care Health Sciences, University of OxfordInstitute for Social Marketing, University of StirlingFaculty of Medicine, University of GenevaNuffield Department of Primary Care Health Sciences, University of OxfordAbstract Background Pivotal trials have established that, among people who have no immediate intention to quit smoking, nicotine replacement therapy (NRT) helps people reduce and eventually stop smoking. The prime aim of this trial was to investigate the feasibility of implementing such a programme in community pharmacies. In addition, we investigated the effectiveness of providing behavioural support compared with self-help methods and of shorter compared with standard length reduction programmes. Methods Pharmacists were trained to deliver a smoking reduction programme and opportunistically invite people to participate in the programme. In a 2 × 2 factorial design, eligible volunteers were randomised to either receive in-person behavioural support or a self-help booklet. In both cases, participants were supported to set targets to reduce their smoking and use behavioural techniques to assist reduction. In addition, participants were randomised to cut down and stop over 4 weeks or over 16 weeks, but in either case continue NRT for up to nine months. We assessed uptake and adherence to the programme and smoking cessation four weeks and six months after a quit day and reduction in the three months following programme end and incorporated a qualitative processes assessment. Results Only 68 of the planned 160 smokers could be recruited. Pharmacists were deterred by the bureaucracy of trial enrolment and that many smokers did not return for further support. Pharmacists sometimes subverted the randomisation or provided support to participants in the self-help arm. Smokers stayed in the programme for an average of 6 weeks rather than the 9 months envisaged. Rates of follow-up declined to around 20% of participants by 12 months. There was insufficient evidence to assess whether support or speed of reduction enhanced cessation or reduction but cessation and reduction were less common overall than in the pivotal trials for licensing NRT for this indication. Conclusions This programme of smoking reduction and the trial design to assess its effectiveness proved unpopular to potential participants and pharmacists. As a result, the trial produced no evidence on the effectiveness of behavioural support or speed or smoking reduction. A trial of this programme in this context is unfeasible. Trial registration ISRCTN 54805841 . Registered 18 March 2010.http://link.springer.com/article/10.1186/s12889-017-4116-z |
spellingShingle | Amanda Farley Sarah Tearne Taina Taskila Rachel H. Williams Susan MacAskill Jean-Francois Etter Paul Aveyard A mixed methods feasibility study of nicotine-assisted smoking reduction programmes delivered by community pharmacists – The RedPharm study BMC Public Health |
title | A mixed methods feasibility study of nicotine-assisted smoking reduction programmes delivered by community pharmacists – The RedPharm study |
title_full | A mixed methods feasibility study of nicotine-assisted smoking reduction programmes delivered by community pharmacists – The RedPharm study |
title_fullStr | A mixed methods feasibility study of nicotine-assisted smoking reduction programmes delivered by community pharmacists – The RedPharm study |
title_full_unstemmed | A mixed methods feasibility study of nicotine-assisted smoking reduction programmes delivered by community pharmacists – The RedPharm study |
title_short | A mixed methods feasibility study of nicotine-assisted smoking reduction programmes delivered by community pharmacists – The RedPharm study |
title_sort | mixed methods feasibility study of nicotine assisted smoking reduction programmes delivered by community pharmacists the redpharm study |
url | http://link.springer.com/article/10.1186/s12889-017-4116-z |
work_keys_str_mv | AT amandafarley amixedmethodsfeasibilitystudyofnicotineassistedsmokingreductionprogrammesdeliveredbycommunitypharmaciststheredpharmstudy AT sarahtearne amixedmethodsfeasibilitystudyofnicotineassistedsmokingreductionprogrammesdeliveredbycommunitypharmaciststheredpharmstudy AT tainataskila amixedmethodsfeasibilitystudyofnicotineassistedsmokingreductionprogrammesdeliveredbycommunitypharmaciststheredpharmstudy AT rachelhwilliams amixedmethodsfeasibilitystudyofnicotineassistedsmokingreductionprogrammesdeliveredbycommunitypharmaciststheredpharmstudy AT susanmacaskill amixedmethodsfeasibilitystudyofnicotineassistedsmokingreductionprogrammesdeliveredbycommunitypharmaciststheredpharmstudy AT jeanfrancoisetter amixedmethodsfeasibilitystudyofnicotineassistedsmokingreductionprogrammesdeliveredbycommunitypharmaciststheredpharmstudy AT paulaveyard amixedmethodsfeasibilitystudyofnicotineassistedsmokingreductionprogrammesdeliveredbycommunitypharmaciststheredpharmstudy AT amandafarley mixedmethodsfeasibilitystudyofnicotineassistedsmokingreductionprogrammesdeliveredbycommunitypharmaciststheredpharmstudy AT sarahtearne mixedmethodsfeasibilitystudyofnicotineassistedsmokingreductionprogrammesdeliveredbycommunitypharmaciststheredpharmstudy AT tainataskila mixedmethodsfeasibilitystudyofnicotineassistedsmokingreductionprogrammesdeliveredbycommunitypharmaciststheredpharmstudy AT rachelhwilliams mixedmethodsfeasibilitystudyofnicotineassistedsmokingreductionprogrammesdeliveredbycommunitypharmaciststheredpharmstudy AT susanmacaskill mixedmethodsfeasibilitystudyofnicotineassistedsmokingreductionprogrammesdeliveredbycommunitypharmaciststheredpharmstudy AT jeanfrancoisetter mixedmethodsfeasibilitystudyofnicotineassistedsmokingreductionprogrammesdeliveredbycommunitypharmaciststheredpharmstudy AT paulaveyard mixedmethodsfeasibilitystudyofnicotineassistedsmokingreductionprogrammesdeliveredbycommunitypharmaciststheredpharmstudy |